|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MNMD | Karlin Dan | Chief Medical Officer | Mar 25 | Sale | 9.50 | 6,578 | 62,491 | 358,452 | Mar 26 05:15 PM |
MNMD | Karlin Dan | Chief Medical Officer | Dec 26 | Sale | 3.63 | 6,774 | 24,590 | 365,030 | Dec 26 04:59 PM |
MNMD | Karlin Dan | Chief Medical Officer | Sep 25 | Sale | 3.57 | 6,918 | 24,730 | 371,804 | Sep 25 09:30 PM |
MNMD | Karlin Dan | Chief Medical Officer | Jun 27 | Sale | 3.20 | 6,783 | 21,697 | 378,722 | Jun 27 07:00 PM |
MNMD | Karlin Dan | Chief Medical Officer | Mar 01 | Sale | 3.51 | 3,577 | 12,555 | 260,505 | Mar 02 09:45 PM |
MNMD | Karlin Dan | Chief Medical Officer | Dec 21 | Sale | 2.69 | 1,211 | 3,258 | 264,082 | Dec 22 04:32 PM |
MNMD | Karlin Dan | Chief Medical Officer | Oct 25 | Sale | 2.81 | 541 | 1,520 | 265,937 | Oct 27 05:52 PM |
MNMD | Karlin Dan | Chief Medical Officer | Oct 27 | Sale | 3.00 | 644 | 1,932 | 265,293 | Oct 27 05:52 PM |
MNMD | Karlin Dan | Chief Medical Officer | Sep 26 | Sale | 5.51 | 565 | 3,113 | 267,118 | Sep 27 08:48 PM |
MNMD | Karlin Dan | Chief Medical Officer | Sep 27 | Sale | 5.87 | 640 | 3,757 | 266,478 | Sep 27 08:48 PM |
MNMD | Karlin Dan | Chief Medical Officer | Aug 31 | Sale | 11.67 | 1,204 | 14,051 | 267,683 | Sep 01 12:24 PM |
MNMD | Karlin Dan | Chief Medical Officer | Jul 25 | Sale | 0.69 | 8,361 | 5,769 | 4,043,120 | Jul 27 07:49 PM |
MNMD | Karlin Dan | Chief Medical Officer | Jul 27 | Sale | 0.69 | 9,856 | 6,801 | 4,033,264 | Jul 27 07:49 PM |
MNMD | Karlin Dan | Chief Medical Officer | Jun 27 | Sale | 0.70 | 26,238 | 18,367 | 4,051,481 | Jun 28 06:04 PM |
MNMD | Karlin Dan | Chief Medical Officer | May 27 | Sale | 0.82 | 9,555 | 7,835 | 4,077,719 | May 31 06:53 PM |
MNMD | Karlin Dan | Chief Medical Officer | May 25 | Sale | 0.77 | 8,242 | 6,346 | 4,087,274 | May 26 09:08 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite